Total planned funding: $283,948,323
Clear active filters
FHI 360
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
| Mozambique | $93,111,873 |
| South Africa | $31,784,928 |
| Kenya | $24,398,447 |
| Zambia | $14,155,221 |
| Ethiopia | $13,553,822 |
| Zimbabwe | $13,334,391 |
| Burundi | $12,744,136 |
| Nigeria | $9,080,493 |
| India | $7,814,357 |
| Côte d'Ivoire | $6,860,855 |
| Malawi | $6,462,109 |
| Vietnam | $5,938,185 |
| Democratic Republic of the Congo | $5,759,261 |
| Haiti | $5,316,452 |
| Indonesia | $4,976,794 |
| Tanzania | $4,104,708 |
| Eswatini | $3,577,374 |
| Asia Regional Program | $3,400,093 |
| Uganda | $3,387,400 |
| Botswana | $3,213,389 |
| Caribbean Region | $2,525,420 |
| Papua New Guinea | $2,486,306 |
| Angola | $2,466,719 |
| Cambodia | $2,025,000 |
| Lesotho | $653,628 |
| South Sudan | $566,962 |
| Dominican Republic | $250,000 |
| Central Asia Region | $0 |
Organizational Types
| NGO | $283,948,323 |
Program Areas
| Care | $94,056,010 |
| Treatment | $79,996,553 |
| Prevention | $66,657,799 |
| Testing | $26,090,675 |
| Governance and Systems | $17,147,286 |
Budget Codes
| HTXS: Treatment: Adult Treatment | $73,015,297 |
| HKID: Care: Orphans and Vulnerable Children | $63,715,751 |
| HVOP: Sexual Prevention: Other Sexual Prevention | $47,179,243 |
| HVCT: Testing: HIV Testing and Counseling | $26,090,675 |
| HBHC: Care: Adult Care and Support | $18,967,201 |
| MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $8,894,709 |
| PDCS: Care: Pediatric Care and Support | $7,091,009 |
| OHSS: Health Systems Strengthening | $6,999,535 |
| PDTX: Treatment: Pediatric Treatment | $6,981,256 |
| HVSI: Strategic Information | $5,875,769 |
| HVAB: Sexual Prevention: Abstinence/Be Faithful | $4,417,907 |
| HVTB: Care: TB/HIV | $4,282,049 |
| HLAB: Laboratory Infrastructure | $4,271,982 |
| CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $3,127,988 |
| IDUP: Prevention: Injecting and Non-Injecting Drug Use | $2,293,362 |
| HMBL: Biomedical Prevention: Blood Safety | $422,932 |
| HMIN: Biomedical Prevention: Injection Safety | $321,658 |
| HTXD: Treatment: ARV Drugs | $0 |